aiqbench analysis
This study reveals that prompting strategies designed to reduce overconfidence in clinical language models produce variable results depending on the specific judge model used. While safety improvements are consistent across different foundation models when measured by a primary LLM judge, these gains often come at a significant cost to diagnostic helpfulness for certain architectures like Gemini 3.5 Flash. The findings underscore that relying solely on automated judges without human calibration can misrepresent both the magnitude of safety benefits and their impact on model utility in high-stakes medical settings.
Judge-dependent safety gains and model-specific helpfulness costs of evidence-sufficiency prompting in clinical LLMs
arXiv:2607.18086v1 Announce Type: new Abstract: Background: LLM judges increasingly score whether clinical language models give overconfident answers under incomplete evidence, yet whether a measured "safety gain" reflects real behavior change or the judge's calibration is unresolved. Using a structured evidence-sufficiency prompt as a test case, we asked whether it reduces unsafe overconfident answers, how far that effect depends on the scoring judge, and what it costs in helpfulness. Methods: In a retrospective public-data benchmark (Real-POCQi, HealthBench, MedRBench), four models (GPT-5.5, Claude Opus 4.8, Gemini 3.5 Flash, Grok 4.3) answered a fully paired common panel (1,200 cells) with a standard prompt and the wrapper. The pre-specified endpoint was the paired reduction in unsafe overconfidence scored by the primary judge (GPT-5.4-nano); secondary analyses added a different-family judge (Claude Sonnet 5), a correctness judge, matched scaffold controls, and a blinded three-clinician review. Results: Unsafe overconfidence fell from 49.3% to 24.7%, a paired reduction of 24.7 points (95% CI 21.8-27.7; p<0.001), robust in direction across models and paraphrases. Magnitude was judge-dependent: Sonnet agreed on direction but nearly halved the effect (+13.1 points), with one-directional disagreement. Blinded clinicians characterized the primary judge as a high-sensitivity (1.00), low-specificity (0.55) screen, not a calibrated rate. The gain carried a model-specific helpfulness cost (correct diagnosis 80.3% to 50.3%): near-free for GPT-5.5, near-total for Gemini (-58 points). Matched scaffold controls showed genuine behavior change, not judge circularity. Conclusions: LLM-judged clinical safety effects should be reported as directional and relative, anchored to human review and evaluated jointly with helpfulness, not as calibrated absolute rates. This does not establish clinical deployment readiness.
Abstract:Background: LLM judges increasingly score whether clinical language models give overconfident answers under incomplete evidence, yet whether a measured "safety gain" reflects real behavior change or the judge's calibration is unresolved. Using a structured evidence-sufficiency prompt as a test case, we asked whether it reduces unsafe overconfident answers, how far that effect depends on the scoring judge, and what it costs in helpfulness. Methods: In a retrospective public-data benchmark (Real-POCQi, HealthBench, MedRBench), four models (GPT-5.5, Claude Opus 4.8, Gemini 3.5 Flash, Grok 4.3) answered a fully paired common panel (1,200 cells) with a standard prompt and the wrapper. The pre-specified endpoint was the paired reduction in unsafe overconfidence scored by the primary judge (GPT-5.4-nano); secondary analyses added a different-family judge (Claude Sonnet 5), a correctness judge, matched scaffold controls, and a blinded three-clinician review. Results: Unsafe overconfidence fell from 49.3% to 24.7%, a paired reduction of 24.7 points (95% CI 21.8-27.7; p<0.001), robust in direction across models and paraphrases. Magnitude was judge-dependent: Sonnet agreed on direction but nearly halved the effect (+13.1 points), with one-directional disagreement. Blinded clinicians characterized the primary judge as a high-sensitivity (1.00), low-specificity (0.55) screen, not a calibrated rate. The gain carried a model-specific helpfulness cost (correct diagnosis 80.3% to 50.3%): near-free for GPT-5.5, near-total for Gemini (-58 points). Matched scaffold controls showed genuine behavior change, not judge circularity. Conclusions: LLM-judged clinical safety effects should be reported as directional and relative, anchored to human review and evaluated jointly with helpfulness, not as calibrated absolute rates. This does not establish clinical deployment readiness.
Artificial Intelligence (cs.AI)
arXiv:2607.18086 [cs.AI]
(or arXiv:2607.18086v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2607.18086 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 350 words
Related coverage

Deconfusing Corrigibility
AI Alignment Forum · Oct 17, 2026

[AINews] Meta Muse Wonder & Wonder Full: MSL’s Claude 5.5-tier Frontier Model
Latent Space · Oct 13, 2026

[AINews] not much happened today
Latent Space · Oct 3, 2026
Untrusted advice for AI control: Short, strong advice significantly uplifts weak LLMs
LessWrong · Jul 27, 2026